NKTX – nkarta, inc. (US:NASDAQ)

News

Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $16.00 to $15.00. They now have a "buy" rating on the stock.
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights [Yahoo! Finance]
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight [Yahoo! Finance]
Nkarta: Down 50% Since March With A Clinical Catalyst Ahead [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com